If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): Route of Administration
Trulicity (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm.
US_cFAQ_GLP059_ROUTE_OF_ADMINISTRATION
en-US
Detailed Information
Dulaglutide should be injected subcutaneously in the abdomen, thigh, or upper arm.1
It must not be injected intravenously or intramuscularly.1
Enclosed Prescribing Information
Reference
1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: November 18, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays